Showing results (171-180 of 801) with videos related to
Sort By:
Pageof 81
Prostaglandins, Leukotrienes, and Medicine|May 1, 1984
Arachidonic acid metabolism by the non-pregnant human uterusL M Demers, M C Rees, A C TurnbullScience (New York, N.Y.)|May 11, 2002
The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanismKaspar P Locher, Allen T Lee, Douglas C ReesHemasphere|August 24, 2022
Precision Medicine and Sickle Cell DiseaseSara El Hoss, Wassim El Nemer, David C ReesCancer Immunology, Immunotherapy : CII|January 15, 2004
Identification of tumour antigens by serological analysis of cDNA expression cloningGeng Li, Amanda Miles, Aija Line, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distributionR J Norman, I H Flight, M C ReesTrends in Pharmacological Sciences|March 31, 2012
Experiences in fragment-based drug discoveryChristopher W Murray, Marcel L Verdonk, David C ReesImmunology|May 1, 1989
Inhibition of pregnancy viability in mice following IL-2 administrationB U Tezabwala, P M Johnson, R C ReesBritish Journal of Cancer|June 1, 1976
Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cellsL P Shah, R C Rees, R W BaldwinBMJ Paediatrics Open|November 7, 2018
High body mass index in children with sickle cell disease: a retrospective single-centre auditRachael Hall, Kate Gardner, David C Rees, et al.Journal of Immunological Methods|January 1, 1978
Studies on the microcytotoxicity test. II. The uptake of amino acids ([3H]leucine or [75Se]methionine) but not nucleosides ([3H]thymidine or [125I]IUdR) or 51CrO24-provides a direct and quantitative measure of target cell survival in the presence of lymphoid cellsC G Brooks, R C Rees, R A RobinsPageof 81